Navigation Links
Pharmaxis Previews New Bronchial Challenge Test at the Annual Meeting of the American College of Allergy, Asthma and Immunology
Date:11/10/2010

EXTON, Pa., Nov. 10, 2010 /PRNewswire/ -- Pharmaxis, a global specialty pharmaceutical company focused on therapeutic products for respiratory and immune disorders, will present ARIDOL™ (mannitol inhalation powder) Bronchial Challenge Test Kit, at the 2010 Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI), November 11-16 in Phoenix, AZ.  

Approved by the U.S. Food and Drug Administration (FDA) on October 5, 2010, ARIDOL is the first new bronchial challenge test in more than two decades.  It is used for the assessment of bronchial hyperresponsiveness in patients six years of age and older who do not have clinically apparent asthma.  The easy-to-administer, single-use test, which delivers dry powder mannitol to the patient through a hand-held inhaler, can be conducted in a variety of healthcare settings including physician offices and pulmonary function labs.  ACAAI meeting attendees can preview ARIDOL and see a demonstration of how it works at the Pharmaxis booth #s1124 and 1126.

ARIDOL is an easy-to-administer, accurate and reproducible bronchial challenge test that requires minimal preparation and administration time.  A positive response is indicated when there is a 15% reduction in lung function from baseline.  

ARIDOL has been found effective and recognized as generally safe in two Phase III global clinical trials. It is widely recognized by experts as a significant addition to the tools available to help in an overall clinical assessment of asthma.  ARIDOL should not be used as a stand-alone tool to assess asthma, but as part of a physician's overall assessment of asthma.

Other Bronchial Challenge Tests

Unlike other bronchial challenge tests, ARIDOL is a single-use test that requires less preparation time, eliminates reconstitution and use of a nebulizer to administer, with little clean-up and sterilization.  A positive ARIDOL test i
'/>"/>

SOURCE Pharmaxis
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Pharmaxis Long-Term Safety Study of Bronchitol Completes
2. Pharmaxis Establishes Named Patient Program for Bronchitol
3. Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial
4. ASX/NASDAQ Media Release: Pharmaxis Files First Marketing Application for Bronchitol in Australia
5. Pharmaxis Announces New Drug Application Submission for Aridol(TM)
6. Pharmaxis Announces Milestone in Phase III Trial for Cystic Fibrosis
7. Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis Trial
8. FDA Approves Pharmaxis ARIDOL™ (Mannitol Inhalation Powder) Bronchial Challenge Test Kit for the Assessment of Bronchial Hyperresponsiveness
9. Pharmaxis Announces Positive Combined Phase 3 Cystic Fibrosis Trial Results
10. Emphasys Medical Granted Expedited Review From FDA for Zephyr(R) Endobronchial Valve
11. Pivotal Data Show Bronchial Thermoplasty Can Improve Quality of Life and Reduce Asthma Attacks and Emergency Room Visits for Adults with Severe Asthma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... LONDON , Sept. 30, 2014 This report ... Million by the following Product Categories: Enteral Feeding Pumps, Nasogastric ... analytics for the US Canada, Japan , ... Latin America , and Rest of World. ... through 2018. Also, a six-year historic analysis is provided for ...
(Date:9/30/2014)... 2014  Hologic, Inc. (NASDAQ: HOLX ), ... and Chief Executive Officer, will preside over the NASDAQ ... first day of Breast Cancer Awareness Month. In his ... on the important benefits of Hologic,s 3D Mammography technology, ... clinically superior to traditional mammography. This is ...
(Date:9/30/2014)... , Sept. 30, 2014  Tasly Pharmaceuticals, ... to modernize medicine, announced today the launch of ... nutraceuticals developed to address men and women concerned ... and vibrant into old age while helping keep ... three condition-specific, whole-food and herb-based formulas, namely, ProHeart ...
Breaking Medicine Technology:Global Enteral Feeding Devices Industry 2Global Enteral Feeding Devices Industry 3Global Enteral Feeding Devices Industry 4Global Enteral Feeding Devices Industry 5Global Enteral Feeding Devices Industry 6Global Enteral Feeding Devices Industry 7Global Enteral Feeding Devices Industry 8Global Enteral Feeding Devices Industry 9Global Enteral Feeding Devices Industry 10Global Enteral Feeding Devices Industry 11Global Enteral Feeding Devices Industry 12Global Enteral Feeding Devices Industry 13Global Enteral Feeding Devices Industry 14Global Enteral Feeding Devices Industry 15Global Enteral Feeding Devices Industry 16Global Enteral Feeding Devices Industry 17Global Enteral Feeding Devices Industry 18Global Enteral Feeding Devices Industry 19Hologic to Kick Off National Breast Cancer Awareness Month at the October 1 NASDAQ Stock Market Opening Bell Ceremony 2Hologic to Kick Off National Breast Cancer Awareness Month at the October 1 NASDAQ Stock Market Opening Bell Ceremony 3
... LYON, France, Oct. 9 Vical Incorporated,(Nasdaq: ... study in mice demonstrated,the potential of its patented ... with a protein-based H5N1 pandemic influenza vaccine,currently stockpiled ... in extending limited vaccine supplies to protect the ...
... - A Total of 13 Abstracts for Eight Compounds Being ... on October 24, 2007 at 6:00 PM PDT -, ... EXEL ) today announced that data from ongoing phase 2 ... non-small cell,lung cancer, respectively, will be presented at the 2007 ...
Cached Medicine Technology:Vical Demonstrates Dose-sparing of Protein-based H5N1 Influenza Vaccine With Vaxfectin(TM) Adjuvant 2Vical Demonstrates Dose-sparing of Protein-based H5N1 Influenza Vaccine With Vaxfectin(TM) Adjuvant 3Vical Demonstrates Dose-sparing of Protein-based H5N1 Influenza Vaccine With Vaxfectin(TM) Adjuvant 4New Data for XL880, XL647 and XL184 to Be Presented at AACR-NCI-EORTC 2New Data for XL880, XL647 and XL184 to Be Presented at AACR-NCI-EORTC 3
(Date:9/30/2014)... By Alan Mozes ... 2014 (HealthDay News) -- Colon cancer patients who are ... slightly higher risk for developing a second weight-related cancer, ... to the risk of colon cancer recurrence, only the ... , "We found that colorectal cancer survivors who reported ...
(Date:9/30/2014)... breast cancer is the leading cause of cancer death ... why so many medical professionals encourage women to get ... only a minority of suspicious mammograms actually leads to ... needless worry for women and their familiesnot to mention ... ultrasounds and biopsies. , Recently, a different type ...
(Date:9/30/2014)... CO September 30, 2014 Keystone Symposia will ... the first in its 2014-15 Global Health Series ... the Sheraton Seattle Hotel immediately following the conclusion ... The four-day conference is part of the Keystone Symposia ... Gates Foundation, which has also funded travel awards for ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 A new ... State University studied the impact of stress on metabolism after ... and french fries from a fast food restaurant, about 930 ... resting metabolism for 20 minutes every hour for 7 hours, ... showed that women who had experienced a stressful event in ...
(Date:9/30/2014)... 30, 2014 Integrated Medicine Alliance ... opening another new medical specialty practice through a unique ... will be located within the company’s Shrewsbury location ... Dr. Isaac Tawfik of American Heart Center, P.C., a ... practice will offer Integrated Medicine Alliance patients top notch ...
Breaking Medicine News(10 mins):Health News:Obesity Tied to Higher Cancer Risk for Colon Cancer Survivors 2Health News:Obesity Tied to Higher Cancer Risk for Colon Cancer Survivors 3Health News:'Virtual breast' could improve cancer detection 2Health News:Keystone Symposia launches 2014-2015 meeting series with Global Health Vaccines Conference 2Health News:NutriGold Urges Every Woman To Read a Recent Study About Diet and Stress 2Health News:NutriGold Urges Every Woman To Read a Recent Study About Diet and Stress 3Health News:Integrated Medicine Alliance Announces New Cardiology Practice 2
... 9 According to Millennium Research Group (MRG), the ... economic crisis is putting pressure on publicly-funded health care ... (IC) device prices in the region. MRG,s ... (Part II) report details the extent to which ...
... ... world,s leading manufacturer and distributor of automated blood pressure monitors and health testing stations, ... ... -- Lifeclinic International has named Lon von Hurwitz Executive Vice President of ...
... July 9 Life Spine announced today that the ... marketing clearance to the FS3 Minimally Invasive Spinal System. ... the FS3 MIS Spinal System offers cannulated wire guided ... range of patient pathologies through a percutaneous or open ...
... Researchers suspect estrogen levels play a part in the connection , ... migraines, here,s a bit of good news: New research shows that ... as 26 percent. , And, no matter what a woman,s age ... of breast cancer is still reduced, according to the study, which ...
... NEW YORK, July 9 Thousands of ... to remain financially afloat. Some are forced to,choose between ... and medications, are being sacrificed and the results can ... difference between,staying healthy and developing a debilitating disease. The ...
... , SARASOTA, Fla., July 9 There,s a new company ... feel trapped - and it is carrying out this ... of products ranging from power wheelchairs and portable oxygen, to ... mobility to people who have trouble getting around. , ...
Cached Medicine News:Health News:European Health Care Institutions Forced to Select Lower-Priced Interventional Cardiology Devices 2Health News:Pioneer of Digital Place-Based Media Joins World's Leading Blood Pressure and Health Kiosk Manufacturer 2Health News:Migraines Linked to Reduced Breast Cancer Risk 2Health News:Keep Healthy in a Poor Economy 2Health News:Keep Healthy in a Poor Economy 3
The STAAR ELASTIC LENS®, is a single piece silicone lens to be placed completely in the capsular bag....
... Lomb SoFlex™ UV-Absorbing, Silicone Posterior ... to be used for primary ... of aphakia in patients 60 ... where a cataractous lens has ...
Liberty Three Piece PMMA Lens with UV Absorber....
Single piece Anterior Chamber PMMA lens, AC depth: 4.9....
Medicine Products: